Roche’s $7.1 Billion Acquisition of Telavant

Davis Polk & Wardwell is advising Roche on the transaction, and Freshfields Bruckhaus Deringer is advising Roivant.Roivant (Nasdaq: ROIV) announced it has entered into a definitive agreement…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here